How to Buy Zhengye Biotechnology Holding Stock

Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs.

Zhengye Biotechnology Holding stock last closed at $5.30, down 4.16% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Zhengye Biotechnology Holding stock is currently +51.43% from its 52-week low of $3.50, and -62.94% from its 52-week high of $14.30.

There are currently 47.17M shares of ZYBT outstanding. The market capitalization of ZYBT is $249.98M. In the last 24 hours, 8900 ZYBT shares were traded.

How to Buy Zhengye Biotechnology Holding Stock

Wondering how to invest in Zhengye Biotechnology Holding stock? Here's how.

  1. Choose where to buy Zhengye Biotechnology Holding stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Zhengye Biotechnology Holding stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit money your brokerage account: Pick your payment method and add your details.
  4. Analyze Zhengye Biotechnology Holding stock: The Zhengye Biotechnology Holding ticker symbol is ZYBT. Is Zhengye Biotechnology Holding stock a good investment? Should you buy shares of ZYBT? How do ZYBT's underlying business fundamentals look? Do top analysts think Zhengye Biotechnology Holding is a good buy? Why has ZYBT's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ZYBT is a good stock to buy).
  5. Execute your ZYBT trade: Decide if you will purchase ZYBT shares at the current market price or use a limit order to buy ZYBT shares at a specific price.
  6. Get the latest news on your ZYBT position: Create a watchlist to important notifications about your new investment in Zhengye Biotechnology Holding shares.

Step 1: Choose where to buy Zhengye Biotechnology Holding stock

You need an online brokerage account to access the NASDAQ market and buy ZYBT stock.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've picked the best brokerage, it's time to fill out some personal information so you can buy ZYBT today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to open a new trading account.
  1. Submit your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you have finished signing up on investing apps, you need to deposit funds:

Check out the video below if you need help depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Zhengye Biotechnology Holding stock

After you have selected the best place to buy Zhengye Biotechnology Holding stock, it's important to analyze their stock prior to investing, so you truly comprehend the risk as well as the upside.

Zhengye Biotechnology Holding Numbers

ZYBT Price
$5.30
1w %
-4.5%
1y %
N/A
5y %
N/A
P/E
151.43x
P/B
6.31x
P/S
9.31x
PEG
N/A
Revenue
$25.99M
Earnings
$1.58M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$249.98M
Next Earnings
N/A
Next Dividend
N/A

ZYBT Overview

WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on ZYBT's stock page.

Is ZYBT stock overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ZYBT's fair value.

Using relative valuations ratios:

  • ZYBT could be undervalued based on its P/E ratio of 151.43x, relative to Biotechnology industry P/E ratio of -207.78x
  • ZYBT may be overvalued based on its P/B ratio of 6.31x, relative to Biotechnology industry P/B ratio of 4.3x

You can access more valuation analysis on ZYBT's stock here.

ZYBT Financials at a glance

Pros:

  • There are more short-term assets than short-term liabilities on the ZYBT balance sheet.
  • ZYBT's operating cash flow of $5.72M allows it to safely service it's debt of $12.05M.
  • There are more short-term assets than long-term liabilities on the ZYBT balance sheet.

Cons:

  • ZYBT profit margin has gone down from 14.9% to 6.1% in the past year.
  • ZYBT has a relatively high debt to equity ratio of 0.5.
  • ZYBT earnings of $2.27M is not sufficient to cover its interest payments.

ZYBT Technical Indicators

SMA10
5.57
SMA20
5.72
SMA50
6.71
SMA100
7.02
SMA200
N/A
MACD
-0.36
MACD Signal
-0.4
MACD Histogram
0.04
RSI
41.65
Stochastic %K
28.78
Stochastic %D
29.91
StochRSI %K
46.97
StochRSI %D
51.77

ZYBT Revenue

Last year, ZYBT earnings were $1.58M. Over the last 2 year, ZYBT's earnings have grown by -51.74% per year. This was slower than the Biotechnology industry average of 6.68%.

Last year, ZYBT revenue was $25.99M. In the last 2 year, ZYBT's revenue has gone up by -17.32% per year. This was slower than the Biotechnology industry average of 45.22%.

Dig into ZYBT's earnings and revenue performance here.

Latest Insiders Trades at ZYBT

In the past year, insiders at ZYBT have not bought or sold any shares.

Get more info about who owns ZYBT shares here.

Does ZYBT provide a stable income stream?

No, Zhengye Biotechnology Holding doesn't provide an income stream by paying out dividends.

What do other traders have to say about ZYBT?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your ZYBT trade

There are two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually sufficient.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given dollar amount, place a limit order.

Press the Open Trade button and eToro will place your order.

If you require more assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest news on your ZYBT position

Now that you own some ZYBT stock, you'll want to stay up-to-date on your new company.

Create a watchlist to keep track of your ZYBT stock.

ZYBT Feed

How to Buy Stock in Zhengye Biotechnology Holding

To reiterate, here are the 6 steps you need to take to buy Zhengye Biotechnology Holding stock right now:

  1. Choose where to buy Zhengye Biotechnology Holding stock
  2. Create a brokerage account
  3. Deposit money your brokerage account
  4. Analyze Zhengye Biotechnology Holding stock
  5. Execute your ZYBT trade
  6. Get the latest news on your ZYBT position

If you need a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your new investment in Zhengye Biotechnology Holding, click below.

NASDAQ: ZYBT
$5.30-0.23 (-4.16%)
Updated Aug 1, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: ZYBT
$5.30-0.23 (-4.16%)
Updated Aug 1, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Zhengye Biotechnology Holding share?

As of Aug 1, 2025, it costs $5.30 to buy one share of Zhengye Biotechnology Holding stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.377 shares of ZYBT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Zhengye Biotechnology Holding stock?

One way to place an order for Zhengye Biotechnology Holding stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.